医学
痴呆
背景(考古学)
医学诊断
医学物理学
疾病
神经影像学
病理
精神科
古生物学
生物
作者
Brian J. Burkett,Jeffrey C. Babcock,Val J. Lowe,Jonathan Graff‐Radford,Rathan M. Subramaniam,Derek R. Johnson
出处
期刊:Clinical Nuclear Medicine
[Ovid Technologies (Wolters Kluwer)]
日期:2022-05-11
卷期号:47 (9): 763-773
被引量:13
标识
DOI:10.1097/rlu.0000000000004251
摘要
Abstract PET imaging plays an essential role in achieving earlier and more specific diagnoses of dementia syndromes, important for clinical prognostication and optimal medical management. This has become especially vital with the recent development of pathology-specific disease-modifying therapy for Alzheimer disease, which will continue to evolve and require methods to select appropriate treatment candidates. Techniques that began as research tools such as amyloid and tau PET have now entered clinical use, making nuclear medicine physicians and radiologists essential members of the care team. This review discusses recent changes in the understanding of dementia and examines the roles of nuclear medicine imaging in clinical practice. Within this framework, multiple cases will be shown to illustrate a systematic approach of FDG PET interpretation and integration of PET imaging of specific molecular pathology including dopamine transporters, amyloid, and tau. The approach presented here incorporates contemporary understanding of both common and uncommon dementia syndromes, intended as an updated practical guide to assist with the sophisticated interpretation of nuclear medicine examinations in the context of this rapidly and continually developing area of imaging.
科研通智能强力驱动
Strongly Powered by AbleSci AI